Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New brief therapy aims to ease anxiety in veterans

NCT ID NCT04829240

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study tested a short, skills-based anxiety treatment for veterans in primary care. 177 veterans with anxiety symptoms were randomly assigned to either the new treatment or usual care. The goal was to see if the brief therapy reduces anxiety and improves daily functioning better than standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Veterans Anxiety Skills Training (VAST) - a brief behavioral intervention
What this could lead to
If it works, this could provide an effective, short-term therapy option for veterans with anxiety in primary care settings.
What could go wrong
This is a relatively small, completed trial. The intervention may not prove more effective than usual care, and results may not apply to all veterans or non-veteran populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

213 people

The number who actually took part.

Started

Aug 2021

Finished

Aug 2025

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Patient Inclusion Criteria: * Veteran, * Age \>=18 years, * Seen in the Syracuse or Western New York VAMC or CBOC primary care clinic in the past 12 months, * Screen positive for current (past 2 weeks) clinically significant anxiety symptoms (\>= 8 on GAD7) Provider Inclusion Criteria: * Current behavioral health provider working in Primary Care-Mental Health Integration (PCMHI) at the VA Syracuse or VA Western New York healthcare system, including full-time, part-time, and trainee status Patient Exclusion Criteria: * Inability to communicate in English (as assessed by study staff); * Hearing impairment that precludes completion of telephone eligibility screening (as assessed by study staff); * Cognitive impairment that precludes informed consent, defined as any of the following: * not able to comprehend the study description or eligibility screening as assessed by study staff, * diagnosis of dementia or severe cognitive impairment per self-report, primary care provider, or Problem List, or * screen positive for cognitive impairment (\>= 3 errors on screener); * Diagnosis of Obsessive-Compulsive Disorder (OCD) or serious mental illness (SMI, i.e., psychotic disorders, bipolar disorder) in Problem List; * Encounter diagnosis of Posttraumatic Stress Disorder (PTSD) within the past 2 years or screen positive for PTSD (\>= 4 for men or \>= 5 for women on the Primary Care PTSD Screen for DSM-5; * Currently in psychotherapy/counseling for anxiety and/or depression, defined as any of the following within the past 30 days: * attending \>= 1 non-intake specialty mental health session, * attending \>= 2 PCMHI sessions, or * being hospitalized for mental health treatment; * Current (past 2 weeks) severe depressive symptoms (\>= 20 on PHQ9); * At imminent risk of suicide, defined as being in need of intensive treatment (e.g., hospitalization) to ensure safety, based on study staff's suicide risk assessment (verified by the PI); * Started or had dosage change in psychotropic medication for anxiety or depression in the past 30 days Provider Exclusion Criteria: * None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Syracuse VA Medical Center, Syracuse, NY

    Syracuse, New York, 13210-2716, United States

  • VA Western New York Healthcare System, Buffalo, NY

    Buffalo, New York, 14215-1129, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.